Mapping large numbers of results may take a few moments.
Search Results
Showing 151 - 200 of 424 results found.
Company | Activity | Company Description | Location | |
---|---|---|---|---|
Company Eppin Pharma Inc. | Activity: Research and Development | Company Description Eppin Pharma is developing a non-hormonal male oral contraceptive. | Location Durham | |
Company ER Therapeutics LLC | Activity: Research and Development | Company Description ER Therapeutics is developing and commercializing therapeutics for cancer. | Location Chapel Hill | |
Company Essential Pharmaceuticals LLC | Activity: Research and Development | Company Description Essential Pharmaceuticals sells organ preservation solutions. | Location Durham | |
Company EternaTear Inc. | Activity: Research and Development | Company Description EternaTear had developed a novel artificial tear formulation that provides long lasting ocular lubrication to offer relief from dry eye. | Location Raleigh | |
Company Evecxia Inc. | Activity: Research and Development | Company Description Evecxia is developing drugs which amplify serotonin synthesis to treat neuropsychiatric conditions for which current therapies are inadequate. | Location Research Triangle Park | |
Company Extrel Therapeutics Inc. | Activity: Research and Development | Company Description Extrel Therapeutics is developing medical devices to protect patients from post-operative infection, pain and inflammation. | Location Raleigh | |
Company EydisBio Inc. | Activity: Research and Development | Company Description Eydis Bio is developing a platform of small molecule therapeutics targeting a variety of diseases driven by aberrant inflammatory/autoimmune processes. | Location Durham | |
Company Eyedesis Biosciences LLC | Activity: Research and Development | Company Description Eyedesis Biosciences is developing a small-molecule macrophage inhibitor for the treatment of neovascular age related macular degeneration. | Location Chapel Hill | |
Company FafaBiotic LLC | Activity: Research and Development | Company Description Fafabiotic develops bioformulations for topical and ingestible probiotics for human health. Fafabiotic also offers consulting services on various aspects of biological product development, from feasibility and technology evaluation to scale-up and readiness for commercialization. | Location Cary | |
Company Fair Products Inc. | Activity: Production and Manufacturing | Company Description Fair Products manufactures and distributes tobacco crop care products including insecticides, sucker control, ripeners and fertilizers. | Location Cary | |
Company FastBack Bio LLC | Activity: Research and Development | Company Description FastBack Bio is developing CAR-T therapy for treatment of solid tumors. | Location Raleigh | |
Company Fennec Pharmaceuticals Inc. | Activity: Research and Development | Company Description Fennec Pharmaceuticals develops a sodium thiosulfate formula for the prevention of ototoxicity from cisplatin in pediatric patients. | Location Research Triangle Park | |
Company Fernel Therapeutics Inc. | Activity: Research and Development | Company Description Fernel Therapeutics develops medical devices and pharmaceuticals for the treatment of benign or non-infectious diseases of the pelvic region. | Location Apex | |
Company FLAG Therapeutics Inc. | Activity: Research and Development | Company Description FLAG Therapeutics develops cancer therapeutics using new classes of small molecules which have selective dual activity: antiangiogenesis and chemotherapeutic. | Location Raleigh | |
Company Flexcell International Corp. | Activity: Production and Manufacturing | Company Description Flexcell International designs and manufactures products for cytomechanics research, studying cellular responses to mechanical forces such as tension or compression. | Location Burlington | |
Company Focal Medical Inc. | Activity: Research and Development | Company Description Focal Medical develops novel therapeutic products based on its local drug delivery technology platform. | Location Cary | |
Company GaiaBiome | Activity: Research and Development | Company Description GaiaBiome develops microorganism-based products designed to remediate soil and improve human and animal health. | Location High Point | |
Company Gateway Bio Inc. | Activity: Research and Development | Company Description Gateway Bio is developing a rapid onset anticoagulant. | Location Durham | |
Company Genebiology Inc. | Activity: Research and Development | Company Description GeneBiology identifies, patents and develops new parenteral formulations of approved drugs for unmet medical needs using the 505b2 regulatory pathway. | Location Research Triangle Park | |
Company GeneCentric Therapeutics Inc. | Activity: Research and Development | Company Description GeneCentric Therapeutics develops molecular diagnostic assays to enable oncologists and their patients to make informed, individualized treatment decisions. | Location Research Triangle Park | |
Company Genencine Therapeutics LLC | Activity: Research and Development | Company Description Genencine Therapeutics develops mRNA vaccines for the prevention and treatment of cancer, viral diseases and autoimmune diseases, as well as mRNA therapeutic drugs for genetic diseases. | Location Durham | |
Company Generys Biopharmaceuticals Corp. | Activity: Research and Development | Company Description Generys BioPharmaceuticals develops drugs, formulations and generics for unmet medical needs. Generys also offers therapeutic pipeline portfolio consulting and management services on a contract basis. | Location Chapel Hill | |
Company GeneVentiv Therapeutics Inc. | Activity: Research and Development | Company Description GeneVentiv Therapeutics is a gene therapy company developing treatments for blood diseases and disorders, including treatments for Hemophilia A and B with or without inhibitors and for Hemophilia Arthropathy, a degenerative joint disease. | Location Raleigh | |
Company GENIE Therapeutics | Activity: Research and Development | Company Description Genie Therapeutics develops a cosmetic gene therapy in a topical cream formulation to reduce wrinkles, regenerate collagen and restore aging skin. The delivery platform will be used to develop wound healing drugs. | Location Winston-Salem | |
Company Genoverde Biosciences Inc. | Activity: Research and Development | Company Description Genoverde Biosciences is developing improved varieties of industrial hemp through traditional breeding and genetic engineering technologies for agricultural and biomedical applications. | Location Raleigh | |
Company Global Vaccines Inc. | Activity: Research and Development | Company Description Global Vaccines is a not-for-profit company that develops vaccines against developing-country diseases such as HIV/AIDS, polio, dengue fever, malaria and viral diarrhea (rotavirus). | Location Chapel Hill | |
Company Glycan Therapeutics Inc. | Activity: Production and Manufacturing | Company Description Glycan Therapeutics offers solutions for design, synthesis, analysis, and validation of glycosaminoglycans (GAGs), specifically heparan sulfate and chondroitin sulfate. Glycan Therapeutics offers research reagents, analytical and microarray services, and a drug development program. | Location Raleigh | |
Company Glycomine Inc. | Activity: Research and Development | Company Description Glycomine is developing orphan drugs for serious rare disorders of metabolism and protein misfolding. | Location Chapel Hill | |
Company Gradient Medical Inc. | Activity: Research and Development | Company Description Gradient Medical develops interventional oncology therapies to treat primary and metastatic tumors using minimally invasive nanosecond pulsed electric fields. | Location Cary | |
Company Green Oil Company LLC | Activity: Production and Manufacturing | Company Description Green Oil processes waste vegetable oil from restaurants to produce fatty acid methyl/ethyl esters for biodiesel and other compounds and additives, plant biomass to produce cannabinoids for health products, biochar and compost for biofiltration, soil amendments and carbon sequestration. | Location Efland | |
Company Grid Therapeutics LLC | Activity: Research and Development | Company Description Grid Therapeutics is developing cancer therapeutics that utilize a unique platform that develops human-derived antibodies for the treatment of multiple cancer types. | Location Durham | |
Company Guerbet LLC | Activity: Production and Manufacturing | Company Description Guerbet manufactures contrast media used in diagnostic imaging tests. | Location Raleigh | |
Company Gusto Global LLC | Activity: Research and Development | Company Description Gusto Global is developing a discovery platform that integrates advanced computational and lab-based discovery tools to develop next-generation microbiome-based therapeutics & diagnostics. | Location Research Triangle Park | |
Company Hedros Biotechnology | Activity: Research and Development | Company Description Hedros Biotechnology has developed a software platform to create custom bacteriophage cocktails, with the goal to eradicate acute hepatopancreatic necrosis disease (AHPND) in shrimp. | Location Raleigh | |
Company Helixomer Inc. | Activity: Research and Development | Company Description Helixomer is developing RNA-based anticoagulants. | Location Raleigh | |
Company Hemo Bioscience Inc. | Activity: Production and Manufacturing | Company Description Hemo Bioscience is an FDA-registered, ISO 13485-accredited manufacturer of blood-typing reagents and diagnostics for the blood-banking industry. | Location Durham | |
Company HIPRA Scientific USA LLC | Activity: Research and Development | Company Description Hipra researches and develops vaccines, diagnostics and pharmaceuticals for animal health. | Location Raleigh | |
Company HOMS LLC | Activity: Production and Manufacturing | Company Description HOMS develops, manufactures and markets natural products for pest management. | Location Pittsboro | |
Company Hoofprint Biome | Activity: Research and Development | Company Description Hoofprint Biome engineers probiotics to eliminate methane from livestock while improving production performance. | Location Raleigh | |
Company HTX Technologies LLC | Activity: Production and Manufacturing | Company Description HTX Technologies develops tissue imaging and molecular imaging technologies, with a primary focus on sample preparation and mass spectrometry imaging. | Location Chapel Hill | |
Company Hudson Therapeutics Inc. | Activity: Research and Development | Company Description Hudson Therapeutics, a subsidiary of Shaperon Inc., conducts global clinical trials and business development for anti-inflammatory and immunology drugs. | Location Research Triangle Park | |
Company Humacyte Inc. | Activity: Research and Development | Company Description Humacyte develops a technology platform that isolates and grows stable investigational human tissue replacements with potential regenerative medicine, vascular and nonvascular surgery applications. | Location Durham | |
Company Iluma Alliance | Activity: Research and Development | Company Description Iluma Alliance develops, manufactures and markets nutritional and health ingredients for animals, as well as nutritional ingredients for humans. This location is the innovation labs and conducts research on feed additives for animal nutrition and health. | Location Durham | |
Company Immorna Biotherapeutics Inc. | Activity: Research and Development | Company Description Immorna Biotherapeutics develops self-replicating and conventional mRNA-based therapeutics and vaccines. | Location Raleigh | |
Company Immunaeon (Winston-Salem) | Activity: Research and Development | Company Description Immunaeon provides services to isolate, analyze, and store healthy immune cells for patients for future immunotherapy treatments. | Location Winston-Salem | |
Company ImmunoReagents Inc. | Activity: Production and Manufacturing | Company Description ImmunoReagents manufactures primary and secondary polyclonal antibodies used in research and in vitro diagnostics for the pharmaceutical and veterinary markets. | Location Raleigh | |
Company Immunovant Inc. | Activity: Research and Development | Company Description Immunovant is a clinical-stage biopharmaceutical company developing treatments for autoimmune diseases. | Location Durham | |
Company IMMvention Therapeutix Inc. | Activity: Research and Development | Company Description IMMvention develops small molecule therapies that inhibit multiple inflammasome receptors to treat both rare and prevalent inflammatory diseases. | Location Research Triangle Park | |
Company Inanovate Inc. | Activity: Research and Development | Company Description Inanovate has developed a patented blood analysis system (the Bio-ID) for diagnostic tests. The first application of the Bio-ID is a new blood test to detect breast cancer recurrence at a stage when it may still be cured. | Location Chapel Hill | |
Company Incyclix Bio LLC | Activity: Research and Development | Company Description Incyclix Bio is developing novel cancer treatments through the selective inhibition of specific CDK (cyclin-dependent kinase) family members to address unmet medical needs of oncology patients. | Location Research Triangle Park |